Sernova Biotherapeutics Inc
SEOVF
$0.1422
$0.01249.55%
OTC PK
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -20.48M | -23.69M | -28.67M | -30.61M | -30.18M |
| Total Depreciation and Amortization | 353.00K | 396.70K | 360.50K | 323.70K | 328.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.14M | 1.18M | 2.09M | 2.49M | 2.57M |
| Change in Net Operating Assets | 4.84M | 8.21M | 6.83M | 7.60M | 5.75M |
| Cash from Operations | -14.15M | -13.90M | -19.39M | -20.19M | -21.54M |
| Capital Expenditure | -- | -- | 0.00 | -7.30K | -20.40K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 6.63M | 8.17M | 9.77M | 13.30M | 9.71M |
| Cash from Investing | 6.63M | 8.17M | 9.77M | 13.30M | 9.69M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -168.50K | -169.10K | -170.50K | -171.30K | -172.10K |
| Issuance of Common Stock | 5.23M | 5.23M | 15.80K | 15.80K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 72.70K | 7.90K | 423.70K | 355.30K | 327.50K |
| Cash from Financing | 3.76M | 3.71M | 197.60K | 146.30K | 113.80K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.76M | -2.02M | -9.42M | -6.75M | -11.73M |